Clinical Trial Update: Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the pharmacokinetics, safety, and exploratory efficacy of RECTIV in adolescents with chronic anal fissure has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fissure

Drugs mentioned

• RECTIV (nitroglycerin)

Snippet

Sponsor: Forest Laboratories | Conditions: Anal Fissure | Phase 4 | Status: WITHDRAWN